Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Mar 09 2023

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-09-2023-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 09, 2023, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases